Exheus successfully completes 900,000 euros capital increase and prepares for international market entry
November 29, 2022 Exheus, a genetics and data science company specializing in RNA analysis, completed a 900,000 euros fund raising, 70% from private funds. Decelera Ventures I FCR was the operation’s lead investor (as a result of Exheus’ participation in the Decelera Menorca program),…
Descargar